A Blueprint to follow

Ok before we begin our analysis of the Insulet (NASDAQ: PODD) earnings we want to provide a warning as we are going to say some nice things about Insulet. Which seems to be trend lately as we have said some nice things about Livongo and even Tandem (NASDAQ: TNDM) lately, although being nice to Tandem didn’t last long. Just in case anyone has been wondering why we’ve been nice to companies that we have previously dumped on it’s not because we were bitch slapped by Momma Kliff. It’s because when they do something good they should . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.

This entry was posted in Email Alerts. Bookmark the permalink.